These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13390294)

  • 1. [Method of disintegration of the central nervous system for verifying the spirochetal doctrine of Steiner in the etiology of multiple sclerosis].
    SIMONS HC
    Rev Neurol (Paris); 1956 May; 94(5):710-4. PubMed ID: 13390294
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging surrogates of multiple sclerosis pathology and their relationship to central nervous system atrophy.
    Meier DS; Weiner HL; Khoury SJ; Guttmann CR
    J Neuroimaging; 2004 Jul; 14(3 Suppl):46S-53S. PubMed ID: 15228759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of oligodendroglia in multiple sclerosis].
    BARONTINI F
    Rass Studi Psichiatr; 1954; 43(3):465-78. PubMed ID: 13204654
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pathological anatomy in multiple sclerosis].
    Duma D; Câmpeanu E; Serban M
    Neurol Psihiatr Neurochir; 1968; 13(6):503-14. PubMed ID: 5719425
    [No Abstract]   [Full Text] [Related]  

  • 5. The pathogenesis of multiple sclerosis: relating human pathology to experimental studies.
    Ludwin SK
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):305-18. PubMed ID: 16691112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the etiology of multiple sclerosis in the light of data on the morphological study of the central nervous system. (Preliminary report)].
    Viting AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1965; 65(11):1641-5. PubMed ID: 5876803
    [No Abstract]   [Full Text] [Related]  

  • 7. T cells and microglia as drivers of multiple sclerosis pathology.
    Friese MA; Fugger L
    Brain; 2007 Nov; 130(Pt 11):2755-7. PubMed ID: 17956912
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential for interferon beta-induced serum antibodies in multiple sclerosis to inhibit endogenous interferon-regulated chemokine/cytokine responses within the central nervous system.
    Shapiro AM; Jack CS; Lapierre Y; Arbour N; Bar-Or A; Antel JP
    Arch Neurol; 2006 Sep; 63(9):1296-9. PubMed ID: 16966508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sodium channels and multiple sclerosis].
    Colotto M; Danese C
    Clin Ter; 2004 Jun; 155(6):245-8. PubMed ID: 15560285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of modern magnetic resonance techniques to monitor disease evolution in multiple sclerosis.
    Filippi M; Rocca MA
    Adv Neurol; 2006; 98():167-83. PubMed ID: 16400834
    [No Abstract]   [Full Text] [Related]  

  • 11. [Artificial raising of the presumable causative organism of multiple sclerosis (Spirochaeta myelophthora Steiner 1931) in USA and the importance of the disintegration methods with thedan blue potassium chlorate for the determination of spirochaetes in the central nervous system].
    SIMONS HC
    Schweiz Z Pathol Bakteriol; 1955; 18(5):1138-9. PubMed ID: 13311480
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple sclerosis: a complicated picture of autoimmunity.
    McFarland HF; Martin R
    Nat Immunol; 2007 Sep; 8(9):913-9. PubMed ID: 17712344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
    Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
    J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis and recurrent disseminated encephalomyelitis are different diseases.
    Poser CM
    Arch Neurol; 2008 May; 65(5):674; author reply 674-5. PubMed ID: 18474749
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis mimics.
    Herndon RM
    Adv Neurol; 2006; 98():161-6. PubMed ID: 16400833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early treatment of multiple sclerosis to prevent neurologic damage.
    Coyle PK
    Neurology; 2008 Dec; 71(24 Suppl 3):S3-7. PubMed ID: 19064872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The insulin-like growth factor system in multiple sclerosis.
    Chesik D; Wilczak N; De Keyser J
    Int Rev Neurobiol; 2007; 79():203-26. PubMed ID: 17531843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell differentiation in the CNS of patients with multiple sclerosis.
    Corcione A; Aloisi F; Serafini B; Capello E; Mancardi GL; Pistoia V; Uccelli A
    Autoimmun Rev; 2005 Nov; 4(8):549-54. PubMed ID: 16214094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis - a response-to-damage model.
    't Hart BA; Hintzen RQ; Laman JD
    Trends Mol Med; 2009 Jun; 15(6):235-44. PubMed ID: 19451035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing central nervous system remyelination in multiple sclerosis.
    Dubois-Dalcq M; Ffrench-Constant C; Franklin RJ
    Neuron; 2005 Oct; 48(1):9-12. PubMed ID: 16202704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.